The critical points of USP <1224> and the regulatory requirements required by the USP and FDA. USP <1224> is very specific on what is required for tech transfer of analytical methods as well as the responsibilities of the participating parties.
In this webinar will discuss the four ways to process analytical method transfers per the USP. Speaker will also go over the FDA guidance document for analytical transfer methods.
Course Objectives:
This webinar will present fundamental principles of a method transfer, examine different strategies, discuss key factors that would influence the transfer of analytical methods from one site to another. Speaker will also discuss this official USP guidance considering FDA and other regulatory bodies and how to conduct and maintain 'the validated state' for a method transfer.
Course Outline:
• Regulatory references USP <1224> and FDA Guidance
• Approaches to analytical method transfer
o Comparative Testing
o Co-validation Between Two or More Laboratories
o Revalidation
o Transfer Waiver
• Responsibilities of participating parties
• Effective planning, execution, and documentation of method transfer
• Elements of a complete method validation
• Regulatory requirements for analytical method transfer
• Requirements as outlined in USP <1224>
• Requirements as outlined in FDA Guidance document
• Planning and executing the analytical transfer validation
• Closing the loop on the transfer process
What You Get:
• Training Materials
• Live Q&A Session with our Expert
• Participation Certificate
• Access to Signup Community (Optional)
• Reward Points
Who Will Benefit:
• Quality Assurance Departments
• Quality Control Departments
• Regulatory Affairs Departments
• Compliance Departments
• Laboratory Managers and Supervisors
• Research and Development Departments
• Analysts
• Consultants
Post Marketing and Regulatory Compliance
Get Instant Access 90 Minutes View Program |
3-hr Virtual Seminar: Developing Documents and Records to Meet the Requirements of ISO,IEC 17025
Get Instant Access 180 Minutes View Program |
FDA Regulatory Control of the Drug Development Process and Investigator Responsibility in the Process
Get Instant Access 90 Minutes View Program |
Understanding the FDA Compounding Pharmacies Guidance
Get Instant Access 60 Minutes View Program |
Vendor Qualification - Evaluating Vendors & Understanding their Capabilities
Get Instant Access 60 Minutes View Program |
Get Instant Access On-Demand Access
Preparing for the ICE Storm: What to Do During I 9 Audits and ICE Raids
Janette S. Levey
Human Resources
Get Instant Access On-Demand Access
OSHA Inspections and Investigations-How to Manage Them
Irwin Dobrushin
Environment Health and Safety | OSHA
Get Instant Access On-Demand Access
29 CFR 1904: OSHA's New Injury Recordkeeping E-Submission Rule
Occupational Safety and Health Administration
Get Instant Access On-Demand Access
Working with Excel Databases: Sort, Filter, Subtotal and More
Cathy Horwitz
Cross Industry | Skill Enhancement
Get Instant Access On-Demand Access
Writing Audit Reports
Jonnie T. Keith CIA, CFE, CGAP, CICA
Governance, Risk and Compliance
Get Instant Access On-Demand Access
BSA Reporting Requirements
Banking and Financial Services Industry
Get Instant Access On-Demand Access
Human Factors-Usability Based on ISO 62366
Medical Device | Diagnostic | Pharmaceutical | Biologics fields
Get Instant Access On-Demand Access
Chat GPT for Project Managers
Charles H. Paul
All FDA Regulated Industry